Sentry Investment Management LLC Organon & Co. Transaction History

Sentry Investment Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$16.59 - $23.77 $5,391 - $7,725	-325 Reduced 19.47%	1,344 $23,000
Q1 2023 Apr 26, 2023	BUY	$21.42 - $32.08 $35,749 - $53,541	1,669 New	1,669 $39,000
Q2 2022 Aug 02, 2022	SELL	$31.66 - $38.9 $10,004 - $12,292	-316 Reduced 16.29%	1,624 $55,000
Q1 2022 May 09, 2022	SELL	$30.45 - $39.36 $9,926 - $12,831	-326 Reduced 14.39%	1,940 $68,000
Q3 2021 Nov 03, 2021	SELL	$28.63 - $35.64 $9,476 - $11,796	-331 Reduced 12.75%	2,266 $74,000
Q2 2021 Aug 04, 2021	BUY	$28.45 - $38.0 $73,884 - $98,686	2,597 New	2,597 $79,000

792

203M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.96B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Sentry Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Sentry Investment Management LLC with notifications on news.